NZ551326A - Gelatine nanoparticles, for use in medicine, and method for the production thereof - Google Patents

Gelatine nanoparticles, for use in medicine, and method for the production thereof

Info

Publication number
NZ551326A
NZ551326A NZ551326A NZ55132605A NZ551326A NZ 551326 A NZ551326 A NZ 551326A NZ 551326 A NZ551326 A NZ 551326A NZ 55132605 A NZ55132605 A NZ 55132605A NZ 551326 A NZ551326 A NZ 551326A
Authority
NZ
New Zealand
Prior art keywords
nanoparticles
gelatin
weight
less
cross
Prior art date
Application number
NZ551326A
Other languages
English (en)
Inventor
Michael Ahlers
Conrad Coester
Klaus Zwiorek
Jan Zillies
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of NZ551326A publication Critical patent/NZ551326A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
NZ551326A 2004-08-20 2005-08-18 Gelatine nanoparticles, for use in medicine, and method for the production thereof NZ551326A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004041340A DE102004041340A1 (de) 2004-08-20 2004-08-20 Nanopartikel und Verfahren zu deren Herstellung
PCT/EP2005/008954 WO2006021367A1 (de) 2004-08-20 2005-08-18 Nanopartikel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
NZ551326A true NZ551326A (en) 2010-04-30

Family

ID=35276582

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ551326A NZ551326A (en) 2004-08-20 2005-08-18 Gelatine nanoparticles, for use in medicine, and method for the production thereof

Country Status (14)

Country Link
US (1) US20080003292A1 (enExample)
EP (1) EP1793810A1 (enExample)
JP (1) JP2008510688A (enExample)
KR (1) KR20070046850A (enExample)
CN (1) CN1988892A (enExample)
AU (1) AU2005276675A1 (enExample)
BR (1) BRPI0514524A (enExample)
CA (1) CA2575407A1 (enExample)
DE (1) DE102004041340A1 (enExample)
IL (1) IL180954A0 (enExample)
MX (1) MX2007001996A (enExample)
NO (1) NO20071458L (enExample)
NZ (1) NZ551326A (enExample)
WO (1) WO2006021367A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325225B2 (en) 2005-12-14 2013-07-04 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007072982A1 (en) * 2005-12-20 2007-06-28 Fujifilm Corporation Protein nanoparticles and the use of the same
JP2007224012A (ja) * 2006-01-30 2007-09-06 Fujifilm Corp 酵素架橋したタンパク質ナノ粒子
SI2032592T1 (sl) 2006-06-12 2013-10-30 Cytos Biotechnology Ag Postopki za pakiranje oligonukleotidov v virusu-podobne delce RNA bakteriofagov
JP2008001764A (ja) * 2006-06-21 2008-01-10 Gunma Univ タンパク質からなる粒子状成形体の製造方法及び、該方法により得られたタンパク質からなる粒子状成形体
JP5275561B2 (ja) * 2006-10-30 2013-08-28 富士フイルム株式会社 水分散可能なナノ粒子
DE602007002784D1 (de) * 2007-03-16 2009-11-26 Univ Nat Chi Nan Bioabbaubares Material mit Nanoporen und elektrischer Leitfähigkeit sowie Herstellungsverfahren dafür
JP2008260705A (ja) * 2007-04-11 2008-10-30 Fujifilm Corp 注射用組成物
JP2008297241A (ja) * 2007-05-31 2008-12-11 Fujifilm Corp ニキビ用皮膚外用剤
DE102007041625A1 (de) * 2007-09-03 2009-03-05 Sinn, Hannsjörg, Dr. Neue Gelatine-Wirkstoff-Konjugate
US9724367B2 (en) * 2010-11-10 2017-08-08 Regenmed (Cayman) Ltd. Injectable formulations for organ augmentation
EP2540287A1 (en) 2011-07-01 2013-01-02 FutureChemistry Continuous flow production of gelatin nanoparticles
DE102011052396A1 (de) * 2011-08-04 2013-02-07 Gelita Ag Verfahren zur Herstellung einer stabilen Dispersion von Nanopartikeln, hergestellte Dispersion und deren Verwendung
JP6851987B2 (ja) * 2015-12-25 2021-03-31 コニカミノルタ株式会社 ゼラチン粒子、ゼラチン粒子の製造方法、ゼラチン粒子内包細胞、およびゼラチン粒子内包細胞の製造方法
US11207258B2 (en) 2016-01-25 2021-12-28 Suntory Holdings Limited Capsule containing functional substance and method for manufacturing said capsule
CN107376008B (zh) 2017-07-21 2019-10-22 深圳华诺生物科技有限公司 一种无机纳米颗粒-明胶核壳结构复合材料颗粒的制备方法
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
WO2021146240A1 (en) 2020-01-13 2021-07-22 Cargill, Incorporated Turkey collagen hydrolysates and methods of making
EP3954399B1 (en) * 2020-04-09 2023-11-15 Plmicromed Co., Ltd. Microbeads for embolization and composition for treating proliferative diseases
KR102386631B1 (ko) * 2020-04-09 2022-04-15 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
KR102645182B1 (ko) * 2021-08-23 2024-03-07 전남대학교산학협력단 젤라틴 가교입자의 제조 방법
KR102861315B1 (ko) * 2022-07-26 2025-09-18 전남대학교산학협력단 작물 생장 촉진용 조성물
US20240049705A1 (en) * 2022-07-26 2024-02-15 Industry Foundation Of Chonnam National University Composition for enhancing growth of plants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
AU671965B2 (en) * 1991-12-05 1996-09-19 Alfatec-Pharma Gmbh Pharmaceutically Applicable Nanosol and Process for Preparing The Same
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
DE19838189A1 (de) * 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
DE60024791T2 (de) * 1999-04-08 2006-07-06 The Johns Hopkins University Antigen-spezifische induktion der peripheren immuntoleranz
US7713551B2 (en) * 2002-09-11 2010-05-11 Elan Pharma International Ltd. Gel stabilized nanoparticulate active agent compositions
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung

Also Published As

Publication number Publication date
KR20070046850A (ko) 2007-05-03
EP1793810A1 (de) 2007-06-13
BRPI0514524A (pt) 2008-06-10
IL180954A0 (en) 2007-07-04
NO20071458L (no) 2007-03-19
US20080003292A1 (en) 2008-01-03
CA2575407A1 (en) 2006-03-02
AU2005276675A1 (en) 2006-03-02
CN1988892A (zh) 2007-06-27
DE102004041340A1 (de) 2006-02-23
WO2006021367A1 (de) 2006-03-02
MX2007001996A (es) 2007-05-10
JP2008510688A (ja) 2008-04-10

Similar Documents

Publication Publication Date Title
US20080003292A1 (en) Nanoparticles and method for the production thereof
Lammel et al. Recombinant spider silk particles as drug delivery vehicles
Fraunhofer et al. Asymmetrical flow field-flow fractionation and multiangle light scattering for analysis of gelatin nanoparticle drug carrier systems
Gan et al. Chitosan nanoparticle as protein delivery carrier—systematic examination of fabrication conditions for efficient loading and release
CA2263765C (en) Methods for the production of protein particles useful for delivery of pharmacological agents
Lin et al. Preparation and in vitro characterization of HSA-mPEG nanoparticles
Patton et al. Engineering temperature-sensitive hydrogel nanoparticles entrapping hemoglobin as a novel type of oxygen carrier
Stolnik et al. The preparation of sub-200 nm biodegradable colloidal particles from poly (β-malic acid-co-benzyl malate) copolymers and their surface modification with Poloxamer and Poloxamine surfactants
WO2007086613A1 (en) Enzymatically crosslinked protein nanoparticles
Wöhl-Bruhn et al. Comparison of in vitro and in vivo protein release from hydrogel systems
van Hell et al. Stabilization of peptide vesicles by introducing inter-peptide disulfide bonds
Florczak et al. Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics
Bajpai et al. Dynamics of controlled release of heparin from swellable crosslinked starch microspheres
Chen et al. Development of a chitosan‐based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin
JP4599550B2 (ja) ナノゲル工学によるハイブリッドゲルの調製とバイオマテリアル応用
Thalhammer-Thurner et al. Albumin-based nanoparticles: small, uniform and reproducible
Iemma et al. Synthesis and release profile analysis of thermo-sensitive albumin hydrogels
JP4665131B2 (ja) 高分子電解質複合体およびその製造方法
Won et al. Preparation and cytotoxicity comparison of type A gelatin nanoparticles with recombinant human gelatin nanoparticles
Elaine et al. Advancing Drug Delivery with Biodegradable Molecularly Imprinted Polymers: From Design to Clinical Prospects
Han et al. Particles made of a novel recombinant spider silk protein rAcSp2 as delivery system for peptide drugs with anti-tumor activity
JP4641721B2 (ja) 生物活性物質を担持するためのもしくは担持した微小粒子を含む組成物、ならびにそれらの調製方法
Madgulkar et al. In vitro and in vivo studies on chitosan beads of losartan duolite AP143 complex, optimized by using statistical experimental design
JP2003261777A (ja) 高圧により形成される分子複合体
Marudova et al. Development and in‐vitro characterization of benzydamine loaded chitosan nanoparticles

Legal Events

Date Code Title Description
PSEA Patent sealed